Effects of Ammonia and Glucosamine on the Heterogeneity of Erythropoietin Glycoforms
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Recombinant human erythropoietin (EPO) is a glycoprotein produced as a therapeutic agent from mammalian cell cultures for the treatment of anemia associated with severe kidney damage. The EPO structure has a high glycan content which is essential for bioactivity but shows considerable molecular heterogeneity. The cell culture conditions that affect the heterogeneity of the glycoforms of EPO are not well understood. However, the accumulation of ammonia in culture is one factor that has been associated with an enhanced heterogeneity of glycoforms. In this report we investigate the metabolic perturbations associated with ammonia and glucosamine that may give rise to an altered pattern of EPO glycosylation. Recombinant human erythropoietin was synthesized in serum‐free cultures of transfected Chinese hamster ovary (CHO) cells. The molecular heterogeneity of erythropoietin was increased by supplementation of cultures with either ammonia or glucosamine. The enhanced molecular heterogeneity was shown to be due to variable glycosylation that resulted in EPO with an enhanced molecular weight and isoelectric point range. Enzymatic removal of the glycan moiety of EPO in all cases resulted in a single molecular form with a molecular weight of 18 000, which corresponded to non‐glycosylated EPO. The variable glycosylation was consistent with reduced sialylation and antennarity of the carbohydrate structures present on the three N‐linked sites of EPO. In the presence of ammonia (>30 mM) the proportion of tetrasialylated and tetraantennary glycan structures were reduced by 73% and 57%, respectively, as determined by HPLC analysis. Such changes were also observed, although to a lesser extent (41% and 37%), by an increase in the glucosamine concentration (>10 mM) in the medium. The enhanced heterogeneity of the glycan structures coincided with a significant increase in the intracellular UDP− N ‐acetylhexosamine (UDP−GNAc) pool. The measured UDP−GNAc level was up to 2 orders of magnitude higher in the presence of either glucosamine or ammonia. However, the changes in the glycosylation profiles induced by either glucosamine or ammonia were significantly different even at the same intracellular UDP‐GNAc concentration. This suggests that the enhanced EPO heterogeneity could not be mediated solely by the increased UDP−GNAc level. Glucosamine (but not ammonia) was shown to cause significant inhibition of glucose transport into the cells, which could induce a different pattern of primary metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schachter, H. (1986) · Biochemistry and Cell Biology · doi:10.1139/o86-026 · Cited by 526
Borys, M. C., Linzer, D. I. H., & Papoutsakis, E. T. (1993) · Nature Biotechnology · doi:10.1038/nbt0693-720 · Cited by 171 · cited 1×
“…and Vassalli, 1986; Borys et al., 1994), lipid composition (Jenkins et al., 1994; Castro et al., 1995), protein content (Castro et al., 1995), pH (Borys et al., 1993), and dissolved oxygen concentration (Kunkel et al., 1998) can all affect the glycoform profile of a recombinant protein secreted…”
BackgroundThorens, B., & Vassalli, P. (1986) · Nature · doi:10.1038/321618a0 · Cited by 147 · cited 2×
“Different effects of ammonia on recombinant protein glycosylation have been reported (Andersen and Goochee, 1995; Borys et al., 1994; Thorens and Vassalli, 1986; Yang and Butler, 2000a).”
Background
Cited by
Optimal and consistent protein glycosylation in mammalian cell culture
Hossler, P., Khattak, S. F., & Li, Z. J. (2009) · Glycobiology · doi:10.1093/glycob/cwp079 · Cited by 669
Trummer, E., Fauland, K., Seidinger, S., Schriebl, K., Lattenmayer, C., Kunert, R., Vorauer‐Uhl, K., Weik, R., Borth, N., Katinger, H., et al. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21013 · Cited by 216
“Furthermore, the accumulation of ammonia, known to increase heterogeneities of Epo glycoforms (Yang and Butler, 2000, 2002), could also be excluded.”
BackgroundModulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose
Gramer, M. J., Eckblad, J. J., Donahue, R., Brown, J., Shultz, C., Vickerman, K., Priem, P., van den Bremer, E. T. J., Gerritsen, J., & van Berkel, P. H. C. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23075 · Cited by 193
Aghamohseni, H., Ohadi, K., Spearman, M., Krahn, N., Moo-Young, M., Scharer, J. M., Butler, M., & Budman, H. M. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.05.024 · Cited by 75
“, 1999) and (ii) ammoia is correlated with the sialylation level through the resulting hanges in internal pH in the Golgi apparatus which causes lower ctivity of glycosyltransferase enzymes (Andersen and Goochee, 994; Yang and Butler, 2002).”
BackgroundMethodInfluentialSelf-citationHa, T. K., Kim, D., Kim, C. L., Grav, L. M., & Lee, G. M. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107831 · Cited by 74
Metadata
- Authors
- Yang, M., & Butler, M.
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2002-01
- Volume
- 18
- Issue
- 1
- Pages
- 129-138
- ISSN
- 1520-6033 (ISSN-L)
- 8756-7938
- OpenAlex
- W2071888779
- Cited by
- 127
- References
- 3
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Ammonia and Glucosamine on the Heterogeneity of Erythropoietin Glycoforms. https://app.cochat.ai/papers/10.1021/bp0101334
- The paper
- Yang, M., & Butler, M. (2002). Effects of Ammonia and Glucosamine on the Heterogeneity of Erythropoietin Glycoforms. Biotechnology Progress. https://doi.org/10.1021/bp0101334
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.